Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 | +$574M | |
| 2 | +$573M | |
| 3 | +$446M | |
| 4 |
Micron Technology
MU
|
+$389M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$387M |
Top Sells
| 1 | +$1.19B | |
| 2 | +$1.11B | |
| 3 | +$557M | |
| 4 |
Autodesk
ADSK
|
+$554M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$490M |
Sector Composition
| 1 | Technology | 34.83% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Protagonist Therapeutics
PTGX
$6.17B
| $231M | 0.1% |
2,649,981
+1,549,160
|
|
||
177
Credo Technology Group
CRDO
$21.4B
| $229M | 0.1% |
1,591,348
+1,422,391
|
|
||
178
T-Mobile US
TMUS
$240B
| $229M | 0.1% |
1,126,529
-744,887
|
|
||
179
Gilead Sciences
GILD
$182B
| $229M | 0.1% |
1,862,114
+203,652
|
|
||
180
Vertiv
VRT
$101B
| $223M | 0.1% |
1,378,890
+45,666
|
|
||
181
Marvell Technology
MRVL
$80.9B
| $221M | 0.1% |
2,606,464
+480,052
|
|
||
182
Pfizer
PFE
$152B
| $219M | 0.1% |
8,786,084
+7,489,189
|
|
||
183
Lennar Class A
LEN
$24.7B
| $219M | 0.1% |
2,127,225
+228,247
|
|
||
184
Descartes Systems
DSGX
$6.21B
| $217M | 0.1% |
2,473,531
+203,614
|
|
||
185
CRH
CRH
$71.3B
| $213M | 0.1% |
1,709,299
+156,151
|
|
||
186
Applied Materials
AMAT
$269B
| $213M | 0.1% |
830,219
+724,759
|
|
||
187
FirstService
FSV
$6.9B
| $213M | 0.1% |
1,367,564
+579,615
|
|
||
188
Dynatrace
DT
$11.6B
| $213M | 0.1% |
4,907,027
-1,116,280
|
|
||
189
Surgery Partners
SGRY
$1.72B
| $209M | 0.09% |
13,537,984
+501,401
|
|
||
190
Crinetics Pharmaceuticals
CRNX
$4B
| $207M | 0.09% |
4,440,691
+581,900
|
|
||
191
Veralto
VLTO
$23.3B
| $202M | 0.09% |
2,025,815
-361,848
|
|
||
192
O'Reilly Automotive
ORLY
$79.3B
| $202M | 0.09% |
2,211,790
-183,493
|
|
||
193
Coca-Cola
KO
$335B
| $200M | 0.09% |
2,865,027
+1,537,993
|
|
||
194
Vanguard Total International Stock ETF
VXUS
$132B
| $200M | 0.09% |
2,648,030
+303,871
|
|
||
195
Dollar Tree
DLTR
$23B
| $199M | 0.09% |
1,614,040
-380,014
|
|
||
196
Merck
MRK
$290B
| $198M | 0.09% |
1,885,140
-230,401
|
|
||
197
Sensient Technologies
SXT
$3.88B
| $196M | 0.09% |
2,084,311
-201,837
|
|
||
198
AST SpaceMobile
ASTS
$26.1B
| $194M | 0.09% |
2,670,067
-132,247
|
|
||
199
OSI Systems
OSIS
$4.65B
| $192M | 0.09% |
752,567
-247,724
|
|
||
|
LGN
200
Legence Corp
LGN
$3.09B
| $189M | 0.08% |
4,401,402
+2,474,220
|
|